National Tuberculosis Institute

Kyrgyzstan, Ukraine, and Uzbekistan Update National Guidelines for Drug-Resistant TB Treatment to Advance National Rollout of Three-Drug, Six-Month Regimen

Retrieved on: 
Monday, September 18, 2023
Interim, TB Alliance, Royal Army Service Corps, Senior, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Margaret Chan, World Health Organization, Miliary tuberculosis, Market access, National Tuberculosis Institute, Innovation, Foreign Affairs, Doctor of Philosophy, Ministry, KOICA, Public health, South Korea, Patient, ITRC, Korea International Cooperation Agency, Physician, MOU, Republican, WHO, Pharmaceutical industry, Heating, ventilation, and air conditioning, Tuberculosis, TB, Dauntless (video game), Republic

PRETORIA, South Africa, Sept. 18, 2023 /PRNewswire/ -- Kyrgyzstan, Ukraine, and Uzbekistan — participants in the LIFT-TB project — have updated their National Tuberculosis (TB) Clinical Guidelines to endorse the all-oral, six-month BPaL/M (bedaquiline + pretomanid + linezolid ± Moxifloxacin) regimen(s) as the national standard for treating most patients with drug-resistant tuberculosis (DR-TB).

Key Points: 
  • Launched in 2020 , LIFT-TB is a program intended to broaden adoption and scale-up of innovative TB cures.
  • As part of LIFT-TB, Kyrgyzstan, Ukraine and Uzbekistan each completed operational research of the BPaL regimen.
  • They have also all committed to scaling up use of the treatment for drug-resistant TB.
  • "It is heartening to see countries participating in LIFT-TB emerge as leaders in scaling up access to new DR-TB treatments.

Kyrgyzstan, Ukraine, and Uzbekistan Update National Guidelines for Drug-Resistant TB Treatment to Advance National Rollout of Three-Drug, Six-Month Regimen

Retrieved on: 
Monday, September 18, 2023
Interim, TB Alliance, Royal Army Service Corps, Senior, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Margaret Chan, World Health Organization, Miliary tuberculosis, Market access, National Tuberculosis Institute, Innovation, Foreign Affairs, Doctor of Philosophy, Ministry, KOICA, Public health, South Korea, Patient, ITRC, Korea International Cooperation Agency, Physician, MOU, Republican, WHO, Pharmaceutical industry, Heating, ventilation, and air conditioning, Tuberculosis, TB, Dauntless (video game), Republic

PRETORIA, South Africa, Sept. 18, 2023 /PRNewswire/ -- Kyrgyzstan, Ukraine, and Uzbekistan — participants in the LIFT-TB project — have updated their National Tuberculosis (TB) Clinical Guidelines to endorse the all-oral, six-month BPaL/M (bedaquiline + pretomanid + linezolid ± Moxifloxacin) regimen(s) as the national standard for treating most patients with drug-resistant tuberculosis (DR-TB).

Key Points: 
  • Launched in 2020 , LIFT-TB is a program intended to broaden adoption and scale-up of innovative TB cures.
  • As part of LIFT-TB, Kyrgyzstan, Ukraine and Uzbekistan each completed operational research of the BPaL regimen.
  • They have also all committed to scaling up use of the treatment for drug-resistant TB.
  • "It is heartening to see countries participating in LIFT-TB emerge as leaders in scaling up access to new DR-TB treatments.

SystemOne Launches Multi-Instrument Medical Diagnostic Network in Tanzania

Retrieved on: 
Wednesday, November 2, 2022
Technology, Medical Devices, General Health, Infectious Diseases, Science, AIDS, Health, Other Science, Research, Other Technology, Telemedicine, Virtual Medicine, Software, Other Health, Networks, Internet, Hardware, Data Management, Stop TB Partnership, Heart, International development, Infection, CEO, HIV, Community, USAID, Technology, COVID-19, UNOPS, Hepatitis C, National Tuberculosis Institute, Maintenance, TB, United, PATH, Patient, Multimedia, Solution, Communication, Vaccine, Pharmaceutical industry, Aspect, Health, Malaria

SystemOne is launching a multi-device version of its digital backbone for medical diagnostics, Aspect, in Tanzania, to help improve TB diagnostics, reduce time to treatment, and eventually track treatment outcomes and efficacy.

Key Points: 
  • SystemOne is launching a multi-device version of its digital backbone for medical diagnostics, Aspect, in Tanzania, to help improve TB diagnostics, reduce time to treatment, and eventually track treatment outcomes and efficacy.
  • View the full release here: https://www.businesswire.com/news/home/20221102005093/en/
    National staff training on TB data use with the Aspect platform, an upgrade of GxAlert, in Arusha Tanzania in October 2022.
  • Jointly supported by USAID IDDS and USAID Stop TB with technical facilitation by SystemOne.
  • Now SystemOne is adding connectivity to the Truenat device, from Molbio, to the diagnostic network in Tanzania.

Fujifilm and Qure.ai Join Hands With IHVN to Accelerate TB Screening in Rural Nigerian Communities

Retrieved on: 
Friday, August 12, 2022
Technology, Health, Radiology, Artificial Intelligence, Philanthropy, Other Science, Research, Medical Devices, Software, Infectious Diseases, General Health, Foundation, Hardware, Science, Death, Federal Ministry of Science and Technology, Heart failure, Oyo, Pneumonia, CEO, X-ray, Algorithm, Diagnosis, Technology, AI, Institute of Human Virology Nigeria, Leprosy, Leadership, Triage, Research, Tuberculosis, Office of the National Coordinator for Health Information Technology, University of Maryland, Baltimore, Founder, Health, Contact tracing, United States Agency for International Development, Federal Ministry of Health (Nigeria), International development, Partnership, National Tuberculosis Institute, Infection, COPD, Electricity, WHO, Virology, USAID, HIV, Solution, Party, TB, Medical imaging, Medical device, Pharmaceutical industry, Fujifilm

The partnership has enabled USAID funded IHVN to deploy ultra-portable X-ray machines embedded with AI for active case finding in Nigerian rural communities.

Key Points: 
  • The partnership has enabled USAID funded IHVN to deploy ultra-portable X-ray machines embedded with AI for active case finding in Nigerian rural communities.
  • Through our efforts (rural dwellers in communities with difficult terrains have been reached with TB care).
  • Our partnership with Fujifilm and Qure.ai for AI enabled TB screening is our most recent initiatives towards community outreach.
  • Together IHVN, Fujifilm and Qure.ai aim to strengthen the systems and structures for tuberculosis detection, treatment, and notification in rural Nigeria.